Skip to main content
. Author manuscript; available in PMC: 2010 Feb 15.
Published in final edited form as: Exp Cell Res. 2008 Aug 15;315(4):649–658. doi: 10.1016/j.yexcr.2008.07.031

Figure 3.

Figure 3

Structures of EGFR kinase domain bound to small molecule kinase inhibitors. (A) Erlotinib - EGFR structure [15]. (B) Lapatinib - EGFR structure [22]. (A) HKI-272 - EGFR structure [72]. The upper panels show the entire EGFR kinase domain with inhibitor bound, revealing the active (A) and inactive (B and C) conformations of EGFR. The lower panels show close-up views of the bound inhibitors.